Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/21/2017 03/22/2017 03/23/2017 03/24/2017 03/27/2017 Date
2.05(c) 2.1(c) 2.11(c) 2.12(c) 2.155 Last
2 015 427 1 500 767 1 146 744 938 340 348 184 Volume
-2.84% +2.44% +0.48% +0.47% +1.65% Change
More quotes
Financials ($)
Sales 2017 15,7 M
EBIT 2017 -22,2 M
Net income 2017 -35,8 M
Debt 2017 -
Yield 2017 -
Sales 2018 41,0 M
EBIT 2018 0,27 M
Net income 2018 1,00 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 424,00
Capi. / Sales2017 21,5x
Capi. / Sales2018 8,23x
Capitalization 337 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
03/20 GERON CORPORATION : Today's Research Reports on Stocks to Watch: Geron and Galen..
03/03 GERON CORP : Other Events, Financial Statements and Exhibits (form 8-K)
03/02 Geron Announces Presentation at American Association for Cancer Research Annu..
03/01 GERON : reports 4Q loss
03/01 GERON CORP : Results of Operations and Financial Condition, Financial Statements..
03/01 Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
03/01 GERON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
02/22 Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Fin..
02/10 GERON CORP : Change in Directors or Principal Officers (form 8-K)
01/09 GERON CORP : Results of Operations and Financial Condition, Regulation FD Disclo..
More news
Sector news : Bio Therapeutic Drugs
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Therapeutic Drugs
Latest Tweets
03/09Geron: Speculative Biotech With Upcoming Catalyst
1
03/08Geron Co. $GERN Rating Reiterated by Needham & Company LLC  
03/06FBR & Co Analysts Boost Earnings Estimates for Geron Co. $GERN  
03/04FY2018 EPS Estimates for Geron Co. Boosted by Analyst $GERN  
03/03BRIEF-Geron Corp says 2 parties to securities class action executed a stipula.. 
More tweets
Qtime:21
News from SeekingAlpha
03/08 GERON : Speculative Biotech With Upcoming Catalyst
03/06 FBR lists prime takeover candidates in biotech
03/01 Geron Corporation's (GERN) CEO John Scarlett on Q4 2016 Results - Earnings Ca..
03/01 Geron beats by $0.01, misses on revenue
02/28 Notable earnings after Wednesday?s close
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 4,17 $
Spread / Average Target 97%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Ho Young Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Independent Director
Robert Jay Spiegel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION2.42%337
AMGEN, INC.13.36%122 060
CELGENE CORPORATION6.59%95 986
GILEAD SCIENCES, INC.-5.73%88 240
REGENERON PHARMACEUTIC..1.61%39 568
ACTELION LTD24.40%29 804
More Results